Bioequivalence Study of Coated Cesol Tablet Formulation Versus Biltricide
Clinical trial NCT04314037 · COMPLETED
Trial details
- NCT number
- NCT04314037
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-07-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.